Flex Pharma (FLKS) reported a loss of $0.71 per share in its second quarter, missing consensus forecast by 4 cents. The company reported revenue of $0.11 million for the second quarter.

Ophthotech (OPHT) reported a loss of $0.85 per share in its second quarter, beating consensus forecast by 20 cents. The company�s revenue for the quarter was $28.2 million, beating consensus forecast by $9.56 million.

Galmed Pharmaceuticals (GLMD) reported a loss of $0.39 per share in its second quarter, missing consensus forecast by 4 cents. The company�s cash balance at the end of the quarter stood at $2.9 million.

Mateon Therapeutics (MATN) reported a loss of $0.14 per share in its second quarter, beating consensus forecast by 5 cents.

Cipher (CPHR) reported a loss of $0.13 per share in its second quarter. The company�s revenue for the quarter was $11.7 million, up 33% on a year-over-year basis.